Bioactive Protein and Peptides Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Bioactive Protein and Peptides in global, including the following market information:
Global Bioactive Protein and Peptides Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bioactive Protein and Peptides Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Bioactive Protein and Peptides companies in 2021 (%)
The global Bioactive Protein and Peptides market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dairy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bioactive Protein and Peptides include Archer Daniels Midland Company (ADM), Kerry Group, Cargill Inc., Omega Protein Corporation, Bunge Ltd, EI du Pont de Nemours, Fonterra Co-operative Group Ltd, Royal DSM and CHS and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bioactive Protein and Peptides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bioactive Protein and Peptides Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Bioactive Protein and Peptides Market Segment Percentages, by Type, 2021 (%)
Global Bioactive Protein and Peptides Market Segment Percentages, by Application, 2021 (%)
Global Bioactive Protein and Peptides Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Bioactive Protein and Peptides revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bioactive Protein and Peptides revenues share in global market, 2021 (%)
Key companies Bioactive Protein and Peptides sales in global market, 2017-2022 (Estimated), (KG)
Key companies Bioactive Protein and Peptides sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Bioactive Protein and Peptides Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bioactive Protein and Peptides Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Bioactive Protein and Peptides companies in 2021 (%)
The global Bioactive Protein and Peptides market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dairy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bioactive Protein and Peptides include Archer Daniels Midland Company (ADM), Kerry Group, Cargill Inc., Omega Protein Corporation, Bunge Ltd, EI du Pont de Nemours, Fonterra Co-operative Group Ltd, Royal DSM and CHS and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bioactive Protein and Peptides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bioactive Protein and Peptides Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Bioactive Protein and Peptides Market Segment Percentages, by Type, 2021 (%)
- Dairy
- Egg & Meat
- Gelatin
- Fish & Insects
- Seafood
- Other
Global Bioactive Protein and Peptides Market Segment Percentages, by Application, 2021 (%)
- Medicine
- Cosmetic
- Other
Global Bioactive Protein and Peptides Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Bioactive Protein and Peptides revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bioactive Protein and Peptides revenues share in global market, 2021 (%)
Key companies Bioactive Protein and Peptides sales in global market, 2017-2022 (Estimated), (KG)
Key companies Bioactive Protein and Peptides sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Archer Daniels Midland Company (ADM)
- Kerry Group
- Cargill Inc.
- Omega Protein Corporation
- Bunge Ltd
- EI du Pont de Nemours
- Fonterra Co-operative Group Ltd
- Royal DSM
- CHS
- Gelita
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Bioactive Protein and Peptides Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bioactive Protein and Peptides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BIOACTIVE PROTEIN AND PEPTIDES OVERALL MARKET SIZE
2.1 Global Bioactive Protein and Peptides Market Size: 2021 VS 2028
2.2 Global Bioactive Protein and Peptides Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bioactive Protein and Peptides Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Bioactive Protein and Peptides Players in Global Market
3.2 Top Global Bioactive Protein and Peptides Companies Ranked by Revenue
3.3 Global Bioactive Protein and Peptides Revenue by Companies
3.4 Global Bioactive Protein and Peptides Sales by Companies
3.5 Global Bioactive Protein and Peptides Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bioactive Protein and Peptides Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bioactive Protein and Peptides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bioactive Protein and Peptides Players in Global Market
3.8.1 List of Global Tier 1 Bioactive Protein and Peptides Companies
3.8.2 List of Global Tier 2 and Tier 3 Bioactive Protein and Peptides Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Bioactive Protein and Peptides Market Size Markets, 2021 & 2028
4.1.2 Dairy
4.1.3 Egg & Meat
4.1.4 Gelatin
4.1.5 Fish & Insects
4.1.6 Seafood
4.1.7 Other
4.2 By Type - Global Bioactive Protein and Peptides Revenue & Forecasts
4.2.1 By Type - Global Bioactive Protein and Peptides Revenue, 2017-2022
4.2.2 By Type - Global Bioactive Protein and Peptides Revenue, 2023-2028
4.2.3 By Type - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
4.3 By Type - Global Bioactive Protein and Peptides Sales & Forecasts
4.3.1 By Type - Global Bioactive Protein and Peptides Sales, 2017-2022
4.3.2 By Type - Global Bioactive Protein and Peptides Sales, 2023-2028
4.3.3 By Type - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
4.4 By Type - Global Bioactive Protein and Peptides Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Bioactive Protein and Peptides Market Size, 2021 & 2028
5.1.2 Medicine
5.1.3 Cosmetic
5.1.4 Other
5.2 By Application - Global Bioactive Protein and Peptides Revenue & Forecasts
5.2.1 By Application - Global Bioactive Protein and Peptides Revenue, 2017-2022
5.2.2 By Application - Global Bioactive Protein and Peptides Revenue, 2023-2028
5.2.3 By Application - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
5.3 By Application - Global Bioactive Protein and Peptides Sales & Forecasts
5.3.1 By Application - Global Bioactive Protein and Peptides Sales, 2017-2022
5.3.2 By Application - Global Bioactive Protein and Peptides Sales, 2023-2028
5.3.3 By Application - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
5.4 By Application - Global Bioactive Protein and Peptides Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Bioactive Protein and Peptides Market Size, 2021 & 2028
6.2 By Region - Global Bioactive Protein and Peptides Revenue & Forecasts
6.2.1 By Region - Global Bioactive Protein and Peptides Revenue, 2017-2022
6.2.2 By Region - Global Bioactive Protein and Peptides Revenue, 2023-2028
6.2.3 By Region - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
6.3 By Region - Global Bioactive Protein and Peptides Sales & Forecasts
6.3.1 By Region - Global Bioactive Protein and Peptides Sales, 2017-2022
6.3.2 By Region - Global Bioactive Protein and Peptides Sales, 2023-2028
6.3.3 By Region - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Bioactive Protein and Peptides Revenue, 2017-2028
6.4.2 By Country - North America Bioactive Protein and Peptides Sales, 2017-2028
6.4.3 US Bioactive Protein and Peptides Market Size, 2017-2028
6.4.4 Canada Bioactive Protein and Peptides Market Size, 2017-2028
6.4.5 Mexico Bioactive Protein and Peptides Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Bioactive Protein and Peptides Revenue, 2017-2028
6.5.2 By Country - Europe Bioactive Protein and Peptides Sales, 2017-2028
6.5.3 Germany Bioactive Protein and Peptides Market Size, 2017-2028
6.5.4 France Bioactive Protein and Peptides Market Size, 2017-2028
6.5.5 U.K. Bioactive Protein and Peptides Market Size, 2017-2028
6.5.6 Italy Bioactive Protein and Peptides Market Size, 2017-2028
6.5.7 Russia Bioactive Protein and Peptides Market Size, 2017-2028
6.5.8 Nordic Countries Bioactive Protein and Peptides Market Size, 2017-2028
6.5.9 Benelux Bioactive Protein and Peptides Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Bioactive Protein and Peptides Revenue, 2017-2028
6.6.2 By Region - Asia Bioactive Protein and Peptides Sales, 2017-2028
6.6.3 China Bioactive Protein and Peptides Market Size, 2017-2028
6.6.4 Japan Bioactive Protein and Peptides Market Size, 2017-2028
6.6.5 South Korea Bioactive Protein and Peptides Market Size, 2017-2028
6.6.6 Southeast Asia Bioactive Protein and Peptides Market Size, 2017-2028
6.6.7 India Bioactive Protein and Peptides Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Bioactive Protein and Peptides Revenue, 2017-2028
6.7.2 By Country - South America Bioactive Protein and Peptides Sales, 2017-2028
6.7.3 Brazil Bioactive Protein and Peptides Market Size, 2017-2028
6.7.4 Argentina Bioactive Protein and Peptides Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bioactive Protein and Peptides Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Bioactive Protein and Peptides Sales, 2017-2028
6.8.3 Turkey Bioactive Protein and Peptides Market Size, 2017-2028
6.8.4 Israel Bioactive Protein and Peptides Market Size, 2017-2028
6.8.5 Saudi Arabia Bioactive Protein and Peptides Market Size, 2017-2028
6.8.6 UAE Bioactive Protein and Peptides Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Archer Daniels Midland Company (ADM)
7.1.1 Archer Daniels Midland Company (ADM) Corporate Summary
7.1.2 Archer Daniels Midland Company (ADM) Business Overview
7.1.3 Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Major Product Offerings
7.1.4 Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.1.5 Archer Daniels Midland Company (ADM) Key News
7.2 Kerry Group
7.2.1 Kerry Group Corporate Summary
7.2.2 Kerry Group Business Overview
7.2.3 Kerry Group Bioactive Protein and Peptides Major Product Offerings
7.2.4 Kerry Group Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.2.5 Kerry Group Key News
7.3 Cargill Inc.
7.3.1 Cargill Inc. Corporate Summary
7.3.2 Cargill Inc. Business Overview
7.3.3 Cargill Inc. Bioactive Protein and Peptides Major Product Offerings
7.3.4 Cargill Inc. Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.3.5 Cargill Inc. Key News
7.4 Omega Protein Corporation
7.4.1 Omega Protein Corporation Corporate Summary
7.4.2 Omega Protein Corporation Business Overview
7.4.3 Omega Protein Corporation Bioactive Protein and Peptides Major Product Offerings
7.4.4 Omega Protein Corporation Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.4.5 Omega Protein Corporation Key News
7.5 Bunge Ltd
7.5.1 Bunge Ltd Corporate Summary
7.5.2 Bunge Ltd Business Overview
7.5.3 Bunge Ltd Bioactive Protein and Peptides Major Product Offerings
7.5.4 Bunge Ltd Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.5.5 Bunge Ltd Key News
7.6 EI du Pont de Nemours
7.6.1 EI du Pont de Nemours Corporate Summary
7.6.2 EI du Pont de Nemours Business Overview
7.6.3 EI du Pont de Nemours Bioactive Protein and Peptides Major Product Offerings
7.6.4 EI du Pont de Nemours Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.6.5 EI du Pont de Nemours Key News
7.7 Fonterra Co-operative Group Ltd
7.7.1 Fonterra Co-operative Group Ltd Corporate Summary
7.7.2 Fonterra Co-operative Group Ltd Business Overview
7.7.3 Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Major Product Offerings
7.7.4 Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.7.5 Fonterra Co-operative Group Ltd Key News
7.8 Royal DSM
7.8.1 Royal DSM Corporate Summary
7.8.2 Royal DSM Business Overview
7.8.3 Royal DSM Bioactive Protein and Peptides Major Product Offerings
7.8.4 Royal DSM Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.8.5 Royal DSM Key News
7.9 CHS
7.9.1 CHS Corporate Summary
7.9.2 CHS Business Overview
7.9.3 CHS Bioactive Protein and Peptides Major Product Offerings
7.9.4 CHS Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.9.5 CHS Key News
7.10 Gelita
7.10.1 Gelita Corporate Summary
7.10.2 Gelita Business Overview
7.10.3 Gelita Bioactive Protein and Peptides Major Product Offerings
7.10.4 Gelita Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.10.5 Gelita Key News
8 GLOBAL BIOACTIVE PROTEIN AND PEPTIDES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Bioactive Protein and Peptides Production Capacity, 2017-2028
8.2 Bioactive Protein and Peptides Production Capacity of Key Manufacturers in Global Market
8.3 Global Bioactive Protein and Peptides Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BIOACTIVE PROTEIN AND PEPTIDES SUPPLY CHAIN ANALYSIS
10.1 Bioactive Protein and Peptides Industry Value Chain
10.2 Bioactive Protein and Peptides Upstream Market
10.3 Bioactive Protein and Peptides Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bioactive Protein and Peptides Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Bioactive Protein and Peptides Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bioactive Protein and Peptides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BIOACTIVE PROTEIN AND PEPTIDES OVERALL MARKET SIZE
2.1 Global Bioactive Protein and Peptides Market Size: 2021 VS 2028
2.2 Global Bioactive Protein and Peptides Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bioactive Protein and Peptides Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Bioactive Protein and Peptides Players in Global Market
3.2 Top Global Bioactive Protein and Peptides Companies Ranked by Revenue
3.3 Global Bioactive Protein and Peptides Revenue by Companies
3.4 Global Bioactive Protein and Peptides Sales by Companies
3.5 Global Bioactive Protein and Peptides Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bioactive Protein and Peptides Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bioactive Protein and Peptides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bioactive Protein and Peptides Players in Global Market
3.8.1 List of Global Tier 1 Bioactive Protein and Peptides Companies
3.8.2 List of Global Tier 2 and Tier 3 Bioactive Protein and Peptides Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Bioactive Protein and Peptides Market Size Markets, 2021 & 2028
4.1.2 Dairy
4.1.3 Egg & Meat
4.1.4 Gelatin
4.1.5 Fish & Insects
4.1.6 Seafood
4.1.7 Other
4.2 By Type - Global Bioactive Protein and Peptides Revenue & Forecasts
4.2.1 By Type - Global Bioactive Protein and Peptides Revenue, 2017-2022
4.2.2 By Type - Global Bioactive Protein and Peptides Revenue, 2023-2028
4.2.3 By Type - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
4.3 By Type - Global Bioactive Protein and Peptides Sales & Forecasts
4.3.1 By Type - Global Bioactive Protein and Peptides Sales, 2017-2022
4.3.2 By Type - Global Bioactive Protein and Peptides Sales, 2023-2028
4.3.3 By Type - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
4.4 By Type - Global Bioactive Protein and Peptides Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Bioactive Protein and Peptides Market Size, 2021 & 2028
5.1.2 Medicine
5.1.3 Cosmetic
5.1.4 Other
5.2 By Application - Global Bioactive Protein and Peptides Revenue & Forecasts
5.2.1 By Application - Global Bioactive Protein and Peptides Revenue, 2017-2022
5.2.2 By Application - Global Bioactive Protein and Peptides Revenue, 2023-2028
5.2.3 By Application - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
5.3 By Application - Global Bioactive Protein and Peptides Sales & Forecasts
5.3.1 By Application - Global Bioactive Protein and Peptides Sales, 2017-2022
5.3.2 By Application - Global Bioactive Protein and Peptides Sales, 2023-2028
5.3.3 By Application - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
5.4 By Application - Global Bioactive Protein and Peptides Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Bioactive Protein and Peptides Market Size, 2021 & 2028
6.2 By Region - Global Bioactive Protein and Peptides Revenue & Forecasts
6.2.1 By Region - Global Bioactive Protein and Peptides Revenue, 2017-2022
6.2.2 By Region - Global Bioactive Protein and Peptides Revenue, 2023-2028
6.2.3 By Region - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
6.3 By Region - Global Bioactive Protein and Peptides Sales & Forecasts
6.3.1 By Region - Global Bioactive Protein and Peptides Sales, 2017-2022
6.3.2 By Region - Global Bioactive Protein and Peptides Sales, 2023-2028
6.3.3 By Region - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Bioactive Protein and Peptides Revenue, 2017-2028
6.4.2 By Country - North America Bioactive Protein and Peptides Sales, 2017-2028
6.4.3 US Bioactive Protein and Peptides Market Size, 2017-2028
6.4.4 Canada Bioactive Protein and Peptides Market Size, 2017-2028
6.4.5 Mexico Bioactive Protein and Peptides Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Bioactive Protein and Peptides Revenue, 2017-2028
6.5.2 By Country - Europe Bioactive Protein and Peptides Sales, 2017-2028
6.5.3 Germany Bioactive Protein and Peptides Market Size, 2017-2028
6.5.4 France Bioactive Protein and Peptides Market Size, 2017-2028
6.5.5 U.K. Bioactive Protein and Peptides Market Size, 2017-2028
6.5.6 Italy Bioactive Protein and Peptides Market Size, 2017-2028
6.5.7 Russia Bioactive Protein and Peptides Market Size, 2017-2028
6.5.8 Nordic Countries Bioactive Protein and Peptides Market Size, 2017-2028
6.5.9 Benelux Bioactive Protein and Peptides Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Bioactive Protein and Peptides Revenue, 2017-2028
6.6.2 By Region - Asia Bioactive Protein and Peptides Sales, 2017-2028
6.6.3 China Bioactive Protein and Peptides Market Size, 2017-2028
6.6.4 Japan Bioactive Protein and Peptides Market Size, 2017-2028
6.6.5 South Korea Bioactive Protein and Peptides Market Size, 2017-2028
6.6.6 Southeast Asia Bioactive Protein and Peptides Market Size, 2017-2028
6.6.7 India Bioactive Protein and Peptides Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Bioactive Protein and Peptides Revenue, 2017-2028
6.7.2 By Country - South America Bioactive Protein and Peptides Sales, 2017-2028
6.7.3 Brazil Bioactive Protein and Peptides Market Size, 2017-2028
6.7.4 Argentina Bioactive Protein and Peptides Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bioactive Protein and Peptides Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Bioactive Protein and Peptides Sales, 2017-2028
6.8.3 Turkey Bioactive Protein and Peptides Market Size, 2017-2028
6.8.4 Israel Bioactive Protein and Peptides Market Size, 2017-2028
6.8.5 Saudi Arabia Bioactive Protein and Peptides Market Size, 2017-2028
6.8.6 UAE Bioactive Protein and Peptides Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Archer Daniels Midland Company (ADM)
7.1.1 Archer Daniels Midland Company (ADM) Corporate Summary
7.1.2 Archer Daniels Midland Company (ADM) Business Overview
7.1.3 Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Major Product Offerings
7.1.4 Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.1.5 Archer Daniels Midland Company (ADM) Key News
7.2 Kerry Group
7.2.1 Kerry Group Corporate Summary
7.2.2 Kerry Group Business Overview
7.2.3 Kerry Group Bioactive Protein and Peptides Major Product Offerings
7.2.4 Kerry Group Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.2.5 Kerry Group Key News
7.3 Cargill Inc.
7.3.1 Cargill Inc. Corporate Summary
7.3.2 Cargill Inc. Business Overview
7.3.3 Cargill Inc. Bioactive Protein and Peptides Major Product Offerings
7.3.4 Cargill Inc. Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.3.5 Cargill Inc. Key News
7.4 Omega Protein Corporation
7.4.1 Omega Protein Corporation Corporate Summary
7.4.2 Omega Protein Corporation Business Overview
7.4.3 Omega Protein Corporation Bioactive Protein and Peptides Major Product Offerings
7.4.4 Omega Protein Corporation Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.4.5 Omega Protein Corporation Key News
7.5 Bunge Ltd
7.5.1 Bunge Ltd Corporate Summary
7.5.2 Bunge Ltd Business Overview
7.5.3 Bunge Ltd Bioactive Protein and Peptides Major Product Offerings
7.5.4 Bunge Ltd Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.5.5 Bunge Ltd Key News
7.6 EI du Pont de Nemours
7.6.1 EI du Pont de Nemours Corporate Summary
7.6.2 EI du Pont de Nemours Business Overview
7.6.3 EI du Pont de Nemours Bioactive Protein and Peptides Major Product Offerings
7.6.4 EI du Pont de Nemours Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.6.5 EI du Pont de Nemours Key News
7.7 Fonterra Co-operative Group Ltd
7.7.1 Fonterra Co-operative Group Ltd Corporate Summary
7.7.2 Fonterra Co-operative Group Ltd Business Overview
7.7.3 Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Major Product Offerings
7.7.4 Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.7.5 Fonterra Co-operative Group Ltd Key News
7.8 Royal DSM
7.8.1 Royal DSM Corporate Summary
7.8.2 Royal DSM Business Overview
7.8.3 Royal DSM Bioactive Protein and Peptides Major Product Offerings
7.8.4 Royal DSM Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.8.5 Royal DSM Key News
7.9 CHS
7.9.1 CHS Corporate Summary
7.9.2 CHS Business Overview
7.9.3 CHS Bioactive Protein and Peptides Major Product Offerings
7.9.4 CHS Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.9.5 CHS Key News
7.10 Gelita
7.10.1 Gelita Corporate Summary
7.10.2 Gelita Business Overview
7.10.3 Gelita Bioactive Protein and Peptides Major Product Offerings
7.10.4 Gelita Bioactive Protein and Peptides Sales and Revenue in Global (2017-2022)
7.10.5 Gelita Key News
8 GLOBAL BIOACTIVE PROTEIN AND PEPTIDES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Bioactive Protein and Peptides Production Capacity, 2017-2028
8.2 Bioactive Protein and Peptides Production Capacity of Key Manufacturers in Global Market
8.3 Global Bioactive Protein and Peptides Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BIOACTIVE PROTEIN AND PEPTIDES SUPPLY CHAIN ANALYSIS
10.1 Bioactive Protein and Peptides Industry Value Chain
10.2 Bioactive Protein and Peptides Upstream Market
10.3 Bioactive Protein and Peptides Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bioactive Protein and Peptides Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Bioactive Protein and Peptides in Global Market
Table 2. Top Bioactive Protein and Peptides Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bioactive Protein and Peptides Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bioactive Protein and Peptides Revenue Share by Companies, 2017-2022
Table 5. Global Bioactive Protein and Peptides Sales by Companies, (KG), 2017-2022
Table 6. Global Bioactive Protein and Peptides Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bioactive Protein and Peptides Price (2017-2022) & (US$/G)
Table 8. Global Manufacturers Bioactive Protein and Peptides Product Type
Table 9. List of Global Tier 1 Bioactive Protein and Peptides Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bioactive Protein and Peptides Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bioactive Protein and Peptides Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bioactive Protein and Peptides Sales (KG), 2017-2022
Table 15. By Type - Global Bioactive Protein and Peptides Sales (KG), 2023-2028
Table 16. By Application – Global Bioactive Protein and Peptides Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bioactive Protein and Peptides Sales (KG), 2017-2022
Table 20. By Application - Global Bioactive Protein and Peptides Sales (KG), 2023-2028
Table 21. By Region – Global Bioactive Protein and Peptides Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bioactive Protein and Peptides Sales (KG), 2017-2022
Table 25. By Region - Global Bioactive Protein and Peptides Sales (KG), 2023-2028
Table 26. By Country - North America Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bioactive Protein and Peptides Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bioactive Protein and Peptides Sales, (KG), 2017-2022
Table 29. By Country - North America Bioactive Protein and Peptides Sales, (KG), 2023-2028
Table 30. By Country - Europe Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bioactive Protein and Peptides Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bioactive Protein and Peptides Sales, (KG), 2017-2022
Table 33. By Country - Europe Bioactive Protein and Peptides Sales, (KG), 2023-2028
Table 34. By Region - Asia Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bioactive Protein and Peptides Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bioactive Protein and Peptides Sales, (KG), 2017-2022
Table 37. By Region - Asia Bioactive Protein and Peptides Sales, (KG), 2023-2028
Table 38. By Country - South America Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bioactive Protein and Peptides Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bioactive Protein and Peptides Sales, (KG), 2017-2022
Table 41. By Country - South America Bioactive Protein and Peptides Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bioactive Protein and Peptides Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bioactive Protein and Peptides Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa Bioactive Protein and Peptides Sales, (KG), 2023-2028
Table 46. Archer Daniels Midland Company (ADM) Corporate Summary
Table 47. Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Product Offerings
Table 48. Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 49. Kerry Group Corporate Summary
Table 50. Kerry Group Bioactive Protein and Peptides Product Offerings
Table 51. Kerry Group Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 52. Cargill Inc. Corporate Summary
Table 53. Cargill Inc. Bioactive Protein and Peptides Product Offerings
Table 54. Cargill Inc. Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 55. Omega Protein Corporation Corporate Summary
Table 56. Omega Protein Corporation Bioactive Protein and Peptides Product Offerings
Table 57. Omega Protein Corporation Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 58. Bunge Ltd Corporate Summary
Table 59. Bunge Ltd Bioactive Protein and Peptides Product Offerings
Table 60. Bunge Ltd Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 61. EI du Pont de Nemours Corporate Summary
Table 62. EI du Pont de Nemours Bioactive Protein and Peptides Product Offerings
Table 63. EI du Pont de Nemours Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 64. Fonterra Co-operative Group Ltd Corporate Summary
Table 65. Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Product Offerings
Table 66. Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 67. Royal DSM Corporate Summary
Table 68. Royal DSM Bioactive Protein and Peptides Product Offerings
Table 69. Royal DSM Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 70. CHS Corporate Summary
Table 71. CHS Bioactive Protein and Peptides Product Offerings
Table 72. CHS Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 73. Gelita Corporate Summary
Table 74. Gelita Bioactive Protein and Peptides Product Offerings
Table 75. Gelita Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 76. Bioactive Protein and Peptides Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 77. Global Bioactive Protein and Peptides Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Bioactive Protein and Peptides Production by Region, 2017-2022 (KG)
Table 79. Global Bioactive Protein and Peptides Production by Region, 2023-2028 (KG)
Table 80. Bioactive Protein and Peptides Market Opportunities & Trends in Global Market
Table 81. Bioactive Protein and Peptides Market Drivers in Global Market
Table 82. Bioactive Protein and Peptides Market Restraints in Global Market
Table 83. Bioactive Protein and Peptides Raw Materials
Table 84. Bioactive Protein and Peptides Raw Materials Suppliers in Global Market
Table 85. Typical Bioactive Protein and Peptides Downstream
Table 86. Bioactive Protein and Peptides Downstream Clients in Global Market
Table 87. Bioactive Protein and Peptides Distributors and Sales Agents in Global Market
Table 1. Key Players of Bioactive Protein and Peptides in Global Market
Table 2. Top Bioactive Protein and Peptides Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bioactive Protein and Peptides Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bioactive Protein and Peptides Revenue Share by Companies, 2017-2022
Table 5. Global Bioactive Protein and Peptides Sales by Companies, (KG), 2017-2022
Table 6. Global Bioactive Protein and Peptides Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bioactive Protein and Peptides Price (2017-2022) & (US$/G)
Table 8. Global Manufacturers Bioactive Protein and Peptides Product Type
Table 9. List of Global Tier 1 Bioactive Protein and Peptides Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bioactive Protein and Peptides Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bioactive Protein and Peptides Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bioactive Protein and Peptides Sales (KG), 2017-2022
Table 15. By Type - Global Bioactive Protein and Peptides Sales (KG), 2023-2028
Table 16. By Application – Global Bioactive Protein and Peptides Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bioactive Protein and Peptides Sales (KG), 2017-2022
Table 20. By Application - Global Bioactive Protein and Peptides Sales (KG), 2023-2028
Table 21. By Region – Global Bioactive Protein and Peptides Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bioactive Protein and Peptides Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bioactive Protein and Peptides Sales (KG), 2017-2022
Table 25. By Region - Global Bioactive Protein and Peptides Sales (KG), 2023-2028
Table 26. By Country - North America Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bioactive Protein and Peptides Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bioactive Protein and Peptides Sales, (KG), 2017-2022
Table 29. By Country - North America Bioactive Protein and Peptides Sales, (KG), 2023-2028
Table 30. By Country - Europe Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bioactive Protein and Peptides Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bioactive Protein and Peptides Sales, (KG), 2017-2022
Table 33. By Country - Europe Bioactive Protein and Peptides Sales, (KG), 2023-2028
Table 34. By Region - Asia Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bioactive Protein and Peptides Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bioactive Protein and Peptides Sales, (KG), 2017-2022
Table 37. By Region - Asia Bioactive Protein and Peptides Sales, (KG), 2023-2028
Table 38. By Country - South America Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bioactive Protein and Peptides Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bioactive Protein and Peptides Sales, (KG), 2017-2022
Table 41. By Country - South America Bioactive Protein and Peptides Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bioactive Protein and Peptides Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bioactive Protein and Peptides Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa Bioactive Protein and Peptides Sales, (KG), 2023-2028
Table 46. Archer Daniels Midland Company (ADM) Corporate Summary
Table 47. Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Product Offerings
Table 48. Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 49. Kerry Group Corporate Summary
Table 50. Kerry Group Bioactive Protein and Peptides Product Offerings
Table 51. Kerry Group Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 52. Cargill Inc. Corporate Summary
Table 53. Cargill Inc. Bioactive Protein and Peptides Product Offerings
Table 54. Cargill Inc. Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 55. Omega Protein Corporation Corporate Summary
Table 56. Omega Protein Corporation Bioactive Protein and Peptides Product Offerings
Table 57. Omega Protein Corporation Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 58. Bunge Ltd Corporate Summary
Table 59. Bunge Ltd Bioactive Protein and Peptides Product Offerings
Table 60. Bunge Ltd Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 61. EI du Pont de Nemours Corporate Summary
Table 62. EI du Pont de Nemours Bioactive Protein and Peptides Product Offerings
Table 63. EI du Pont de Nemours Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 64. Fonterra Co-operative Group Ltd Corporate Summary
Table 65. Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Product Offerings
Table 66. Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 67. Royal DSM Corporate Summary
Table 68. Royal DSM Bioactive Protein and Peptides Product Offerings
Table 69. Royal DSM Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 70. CHS Corporate Summary
Table 71. CHS Bioactive Protein and Peptides Product Offerings
Table 72. CHS Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 73. Gelita Corporate Summary
Table 74. Gelita Bioactive Protein and Peptides Product Offerings
Table 75. Gelita Bioactive Protein and Peptides Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2017-2022)
Table 76. Bioactive Protein and Peptides Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 77. Global Bioactive Protein and Peptides Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Bioactive Protein and Peptides Production by Region, 2017-2022 (KG)
Table 79. Global Bioactive Protein and Peptides Production by Region, 2023-2028 (KG)
Table 80. Bioactive Protein and Peptides Market Opportunities & Trends in Global Market
Table 81. Bioactive Protein and Peptides Market Drivers in Global Market
Table 82. Bioactive Protein and Peptides Market Restraints in Global Market
Table 83. Bioactive Protein and Peptides Raw Materials
Table 84. Bioactive Protein and Peptides Raw Materials Suppliers in Global Market
Table 85. Typical Bioactive Protein and Peptides Downstream
Table 86. Bioactive Protein and Peptides Downstream Clients in Global Market
Table 87. Bioactive Protein and Peptides Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Bioactive Protein and Peptides Segment by Type
Figure 2. Bioactive Protein and Peptides Segment by Application
Figure 3. Global Bioactive Protein and Peptides Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bioactive Protein and Peptides Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bioactive Protein and Peptides Revenue, 2017-2028 (US$, Mn)
Figure 7. Bioactive Protein and Peptides Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Bioactive Protein and Peptides Revenue in 2021
Figure 9. By Type - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 10. By Type - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bioactive Protein and Peptides Price (US$/G), 2017-2028
Figure 12. By Application - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 13. By Application - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bioactive Protein and Peptides Price (US$/G), 2017-2028
Figure 15. By Region - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 16. By Region - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 19. US Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 24. Germany Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 25. France Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 33. China Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 37. India Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 40. Brazil Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 44. Turkey Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bioactive Protein and Peptides Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production Bioactive Protein and Peptides by Region, 2021 VS 2028
Figure 50. Bioactive Protein and Peptides Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Bioactive Protein and Peptides Segment by Type
Figure 2. Bioactive Protein and Peptides Segment by Application
Figure 3. Global Bioactive Protein and Peptides Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bioactive Protein and Peptides Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bioactive Protein and Peptides Revenue, 2017-2028 (US$, Mn)
Figure 7. Bioactive Protein and Peptides Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Bioactive Protein and Peptides Revenue in 2021
Figure 9. By Type - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 10. By Type - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bioactive Protein and Peptides Price (US$/G), 2017-2028
Figure 12. By Application - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 13. By Application - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bioactive Protein and Peptides Price (US$/G), 2017-2028
Figure 15. By Region - Global Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 16. By Region - Global Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 19. US Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 24. Germany Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 25. France Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 33. China Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 37. India Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 40. Brazil Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bioactive Protein and Peptides Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bioactive Protein and Peptides Sales Market Share, 2017-2028
Figure 44. Turkey Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bioactive Protein and Peptides Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bioactive Protein and Peptides Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production Bioactive Protein and Peptides by Region, 2021 VS 2028
Figure 50. Bioactive Protein and Peptides Industry Value Chain
Figure 51. Marketing Channels
